Tobin Schilke, CFO: Crinetics Pharmaceuticals CRNX Sell · Filed 03/04

Trade details

Type: Insider sale
Amount: $266,304.71
Shares · price: 6,713 sh · $39.67 a share
Held after: 78,121 sh
Stock: Crinetics Pharmaceuticals CRNX
Person: Tobin SchilkeCFO
Trade date: 26/03/03
Filed: 26/03/04
Days to filing: 1 days

Sold 7.9% of holdings

Share of holding sold: 7.9%

Crinetics Pharmaceuticals trades, last 26 weeks

What else happened in Crinetics Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 02/01~04/02

Tobin Schilke's recent trades

Tobin SchilkeCFO
SellRevance Therapeutics
Sell
Revance Therapeutics
RVNC
$47.2K
9,361 sh
$47.2K
Filed 24/03/19
Traded 24/03/18
Tobin SchilkeCFO
Sell10b5-1 planRevance Therapeutics
Sell10b5-1 plan
Revance Therapeutics
RVNC
$42.6K
1,701 sh
$42.6K
Filed 23/07/05
Traded 23/07/03
Tobin SchilkeCFO
Sell10b5-1 planRevance Therapeutics
Sell10b5-1 plan
Revance Therapeutics
RVNC
$82.6K
2,701 sh
$82.6K
Filed 23/06/05
Traded 23/06/01
Tobin SchilkeCFO
Sell10b5-1 planRevance Therapeutics
Sell10b5-1 plan
Revance Therapeutics
RVNC
$15.5K
500 sh
$15.5K
Filed 23/06/05
Traded 23/06/02
Tobin SchilkeCFO
SellRevance Therapeutics
Sell
Revance Therapeutics
RVNC
$739.4K
21,401 sh
$739.4K
Filed 23/05/16
Traded 23/05/15